Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-07 · accession 0001610717-25-000375 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-11-12 | 2025-11-12 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | G - Gift | $0.00 | -100.0K | 247.9K | -29% | $0 |
| DMTI | 2025-11-12 | 2025-11-12 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | G - Gift | $0.00 | +100.0K | 54.5K | New | $0 |
| DT | 2025-11-12 | 2025-11-07 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $60.31 | -30.0K | 347.9K | -8% | -$1.81M |
| DMT | 2025-11-12 | 2025-11-07 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $1.47 | +30.0K | 377.9K | +9% | +$44.1K |
| DMT | 2025-11-12 | 2025-11-07 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.00 | -30.0K | 177.7K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-12 | G | D | 50,000 | $0.00 | 297,863 | D | — | — | (F2) Reflects the transfer of 104,446 shares previously held directly by the Reporting Person into a family trust. (F3) Includes 193,475 restricted stock units. |
| 2 | Common | Common Stock | 2025-11-12 | G | D | 50,000 | $0.00 | 247,863 | D | — | — | (F2) Reflects the transfer of 104,446 shares previously held directly by the Reporting Person into a family trust. (F3) Includes 193,475 restricted stock units. |
| 3 | Common | Common Stock | 2025-11-12 | G | A | 50,000 | $0.00 | 70,424 | I | — | — | |
| 4 | Common | Common Stock | 2025-11-07 | S | D | 30,000 | $60.31 | 347,863 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $60.00 to $60.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Reflects the transfer of 104,446 shares previously held directly by the Reporting Person into a family trust. (F3) Includes 193,475 restricted stock units. |
| 5 | Common | Common Stock | 2025-11-12 | G | A | 50,000 | $0.00 | 54,498 | I | — | — | (F8) Reflects the transfer of 4,498 shares. |
| 6 | Common | Common Stock | 2025-11-07 | M | A | 26,479 | $1.12 | 374,342 | D Trust | — | — | (F2) Reflects the transfer of 104,446 shares previously held directly by the Reporting Person into a family trust. (F3) Includes 193,475 restricted stock units. (F7) Held by Jonathan Goldsmith Revocable Trust. |
| 7 | Common | Common Stock | 2025-11-07 | M | A | 3,521 | $4.09 | 377,863 | D Trust | — | — | (F2) Reflects the transfer of 104,446 shares previously held directly by the Reporting Person into a family trust. (F3) Includes 193,475 restricted stock units. (F9) Held by Rebecca Goldsmith Revocable Trust. |
| 8 | Derivative | Stock Option (Right to Buy) | 2025-11-07 | M | D | 26,479 | $0.00 | 0 | D | $1.12 · 2022-03-29 to 2028-04-19 | 26,479 Common Stock | |
| 9 | Derivative | Stock Option (Right to Buy) | 2025-11-07 | M | D | 3,521 | $0.00 | 177,708 | D | $4.09 · 2023-03-13 to 2029-03-12 | 3,521 Common Stock |